Press Releases

 
Press Releases
Date Title and Summary View
Dec 18, 2014 NOVATO, Calif., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced the appointment of Gregg Lapointe and Georges Gemayel, Ph.D. to its Board of Directors, effective January 1, 2015. As previously disclosed, they will be joining Julie Anne Smith, President and CEO-Designate as she succeeds Christopher Starr, ...
Dec 1, 2014 NOVATO, Calif., Dec. 1, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that on November 25, 2014, as a key requirement of the Company's strategy of strengthening its leadership team and employee base, continuing the expansion of its commercial activities into new territories, and increasing the expansion of its p...
Nov 18, 2014 NOVATO, Calif., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will participate in the following conference: Julie Anne Smith, President and Chief Executive Officer-Designate, will present at the 26th Annual Piper Jaffray Healthcare Conference on Tuesday, December 2, 2014, at 9:10 a...
Nov 6, 2014 Global Net Product Sales for PROCYSBI® of $23.8 Million for Third Quarter 2014 PROCYSBI Revenue of $52.2 Million Reached Through September2014 PROCYSBI Revenue Guidance of $65-$70 Million Maintained2014 Cash Operating Expense Guidance Narrowed to $80-$85 MillionCompany to Host Conference Call and Webcast Today at 4:30 p.m. ET NOVATO, Calif...
Oct 29, 2014 NOVATO, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that the company will release third quarter 2014 financial results on Thursday, November 6, 2014 after market close. Management will conduct a conference call and live audio webcast at 4:30 p.m. ET (1:30 p.m. PT) that day to discuss the finan...
Oct 23, 2014 NOVATO, Calif., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that it has strengthened its leadership team with the hiring of two new executives: David Happel, Chief Commercial Officer, who will oversee Raptor's global commercial operations, and Kimberly Lee, D.O., Vice President, Corporate Strategy and...
Sep 23, 2014 NOVATO, Calif., Sept. 23, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Leerink Rare Disease Roundtable in New York on Wednesday, October 1, 2014 at 1:30 p.m. EDT/10:30 a.m. PDT. A live audio webcast and archive of the presentation will be available on the company webs...
Aug 27, 2014 NOVATO, Calif., Aug. 27, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 10, 2014 at 11:30 a.m. EDT/8:30 a.m. PDT. A live audio webcast and archive of the presentation will be available on th...
Aug 7, 2014 Global net product sales for PROCYSBI® of $16.3 million reported for second quarter 2014 Raising net sales guidance for PROCYSBI to $65 to $70 million for 2014 Company to host conference call and webcast today at 4:30 p.m. EDT NOVATO, Calif., Aug. 7, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP)...
Aug 6, 2014 NOVATO, Calif., Aug. 6, 2014 (GLOBE NEWSWIRE) -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced that company management will present at the Canaccord Genuity Annual Growth Conference in Boston on Wednesday, August 13, 2014 at 5:00 p.m. EDT/2:00 p.m. PDT. Georgia Erbez, CFO of Raptor, will present an update on the company's commercial act...
Page:
1
... NextLast
= add release to Briefcase